Terminally Ill Access to Treatment Act of 1998
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Terminally Ill Access to Treatment Act of 1998 - Directs the Secretary of Health and Human Services to approve for treating the terminally ill drugs and devices that have not received Food and Drug Administration (FDA) final approval and have not been shown to be unsafe. Declares that it is not illegal for a health care practitioner to administer a drug or device approved under this Act if the practitioner has notified the patient that the drug or device is experimental and not FDA-approved, and has received written approval from the patient or the patient's representative.
Requires: (1) a practitioner to stop treatment and report to the Secretary if a drug or device causes acute harm; and (2) the Secretary to give public notice of an approved drug's or device's benefits or harm.
Referred to the Subcommittee on Health and Environment.
- Introduced in House Formatted Text PDF
Cite this page
U.S. Congress. (2026). H.R. 3938: Terminally Ill Access to Treatment Act of 1998. 105th Congress. Open America. https://openamerica.io/bill/105-HR-3938/
"H.R. 3938: Terminally Ill Access to Treatment Act of 1998." 105th Congress, 2026, Open America, https://openamerica.io/bill/105-HR-3938/.
H.R. 3938, 105th Cong. (2026), https://openamerica.io/bill/105-HR-3938/.
[H.R. 3938: Terminally Ill Access to Treatment Act of 1998](https://openamerica.io/bill/105-HR-3938/)